The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus AstraZeneca Strengthens Its Hematological ...

Related Keywords

Illinois ,United States ,Chicago ,Joseph Edelman ,Codiak Biosciences ,Iveric Bio ,Seth Lederman ,Syros Pharma ,Brickell Biotech Inc ,Astrazeneca Plc ,Nasdaq ,Vertex Pharmaceuticals Incorporated ,Coalition For Epidemic Preparedness Innovations ,Athira Pharma Inc ,Karuna Therapeutics Inc ,Astrazeneca ,Tonix Pharmaceuticals Holding Corp ,Abeona Therapeutics Inc ,Delsitech Ltd ,European Commission ,Impax Laboratories Inc ,Advisory Committee On Immunization Practices ,Amneal Pharmaceuticals Inc ,Seagen Inc ,Teneotwo Inc ,Technologies Inc ,Syros Pharmaceuticals Inc ,Chinook Therapeutics Inc ,Endo International ,Zeneca Plc ,Pharmaceuticals Inc ,Higher Dose Vaccines For ,Fluzone High Dose Quadrivalent ,Flublok Quadrivalent ,Immunization Practices ,Trial Concludes With Jury Verdict Favoring ,Delsitech Ink Licensing Pact For ,Analyst Cuts Price Target On Tesla ,Biggest Price Target Changes For ,Epidemic Preparedness Innovations ,Orphan Medicinal Products ,European Medicines ,Clinical Hold On Vertex Pharma ,Stem Cell Derived Diabetes Treatment ,Therapeutics Inc ,Pharma Inc ,Director Joseph Edelman ,Pharmaceuticals Holding Corp ,Biotech Inc ,